Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 5/20 | 0.62 |
| ▸ | MGAM | O43451 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.49 |
| ▸ | RELA | Q04206 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3950033 | 0.87 | CNR2 (0.61) | CNR2MGAMSMN1; SMN2KDM4ERAB9A | |
| SCHEMBL9867679 | 0.86 | CNR2 (0.65) | CNR2MGAMSMN1; SMN2KDM4ERAB9A | |
| SCHEMBL28605670 | 0.77 | CNR2 (0.62) | CNR2MGAMSMN1; SMN2KDM4ERAB9A | |
| SCHEMBL7832199 | 0.77 | CNR2 (1.00) | CNR2MGAMSMN1; SMN2KDM4ERAB9A | |
| SCHEMBL30227109 | 0.77 | CNR2 (1.00) | CNR2MGAMSMN1; SMN2KDM4ERAB9A | |
| SCHEMBL27838449 | 0.76 | CNR2 (0.96) | CNR2MGAMSMN1; SMN2KDM4ERAB9A | |
| SCHEMBL8822077 | 0.75 | CNR2 (0.51) | CNR2MGAMSMN1; SMN2KDM4ERAB9A | |
| SCHEMBL9695920 | 0.74 | CNR2 (0.59) | CNR2MGAMSMN1; SMN2KDM4ERAB9A | |
| SCHEMBL12256867 | 0.74 | MGAM (0.64) | CNR2MGAMSMN1; SMN2KDM4ERAB9A | |
| SCHEMBL4596660 | 0.74 | MGAM (0.64) | CNR2MGAMSMN1; SMN2KDM4ERAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9321730-B2 | Method of making and administering quinoline derivatives as anti-cancer agents | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2016-04-26 | — | — | US | claimed |
| US-20090054482-A1 | Method of making and administering quinoline derivatives as anti-cancer agents | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2009-02-26 | — | — | US | claimed |
| US-9887368-B2 | Organic light-emitting device and method for manufacturing same | LG CHEM, LTD. (KR) | 2018-02-06 | — | — | US | disclosed |
| US-8956738-B2 | Organic element for low voltage electroluminescent devices | GLOBAL OLED TECHNOLOGY LLC (US) | 2015-02-17 | — | — | US | disclosed |
| US-20140048792-A1 | ORGANIC LIGHT-EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | LG CHEM, LTD. (KR) | 2014-02-20 | — | — | US | disclosed |
| US-7767317-B2 | Organic element for low voltage electroluminescent devices | GLOBAL OLED TECHNOLOGY LLC (US) | 2010-08-03 | — | — | US | disclosed |
| US-20100019671-A1 | ORGANIC ELEMENT FOR LOW VOLTAGE ELECTROLUMINESCENT DEVICES | EASTMAN KODAK COMPANY | 2010-01-28 | — | — | US | disclosed |
| US-20090162644-A1 | ORGANIC ELEMENT FOR LOW VOLTAGE ELECTROLUMINESCENT DEVICES | GLOBAL OLED TECHNOLOGY LLC | 2009-06-25 | — | — | US | disclosed |
| US-20090162612-A1 | OLED DEVICE HAVING TWO ELECTRON-TRANSPORT LAYERS | GLOBAL OLED TECHNOLOGY LLC | 2009-06-25 | — | — | US | disclosed |
| US-20080176099-A1 | WHITE OLED DEVICE WITH IMPROVED FUNCTIONS | GLOBAL OLED TECHNOLOGY LLC | 2008-07-24 | — | — | US | disclosed |
| US-20080032123-A1 | DUAL ELECTRON-TRANSPORTING LAYER FOR OLED DEVICE | GLOBAL OLED TECHNOLOGY LLC | 2008-02-07 | — | — | US | disclosed |
| US-20070207347-A1 | Organic element for low voltage electroluminescent devices | EASTMAN KODAK COMPANY | 2007-09-06 | — | — | US | disclosed |
| US-20070092754-A1 | Organic element for low voltage electroluminescent devices | EASTMAN KODAK COMPANY | 2007-04-26 | — | — | US | disclosed |
| US-20070092753-A1 | Organic element for low voltage electroluminescent devices | EASTMAN KODAK COMPANY | 2007-04-26 | — | — | US | disclosed |
| US-20070092756-A1 | Organic element for low voltage electroluminescent devices | EASTMAN KODAK COMPANY | 2007-04-26 | — | — | US | disclosed |
| US-20070092759-A1 | Organic element for low voltage electroluminescent devices | GLOBAL OLED TECHNOLOGY LLC | 2007-04-26 | — | — | US | disclosed |
| US-20070092755-A1 | Organic element for low voltage electroluminescent devices | EASTMAN KODAK COMPANY | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054482-A1 | Method of making and administering quinoline derivatives as anti-cancer agents | HCCS, GLS2, NQO1 | CNR2 2430/4885MGAM 3758/4885SMN1; SMN2 4005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.